Retour
Fourchette du Jour
22,74 €
23,41 €
Fourchette 52 Semaines
11,43 €
31,04 €
Volume
2 853 634
Moyenne 50J / 200J
17,68 €
/
19,87 €
Clôture Précédente
22,73 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -1,9 | 0,4 |
| P/B | 1,1 | 2,9 |
| ROE % | -43,9 | 3,7 |
| Net Margin % | -33,3 | 3,8 |
| Rev Growth 5Y % | 9,4 | 10,0 |
| D/E | 1,4 | 0,2 |
Points Clés
Revenue grew 9,38% annually over 5 years — modest growth
Earnings declined -531,42% over the past year
Negative free cash flow of -439,91M
PEG of 0,00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,34%
Croissance
Revenue Growth (5Y)
9,38%
Revenue (1Y)5,04%
Earnings (1Y)-531,42%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-43,91%
ROIC6,32%
Net Margin-33,29%
Op. Margin11,71%
Sécurité
Debt / Equity
1,36
Current Ratio1,55
Interest Coverage2,79
Valorisation
P/E Ratio
-1,94
P/B Ratio1,10
EV/EBITDA12,01
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,04% | Revenue Growth (3Y) | 6,35% |
| Earnings Growth (1Y) | -531,42% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9,38% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,31B | Net Income (TTM) | -1,10B |
| ROE | -43,91% | ROA | -19,95% |
| Gross Margin | 17,61% | Operating Margin | 11,71% |
| Net Margin | -33,29% | Free Cash Flow (TTM) | -439,91M |
| ROIC | 6,32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,36 | Current Ratio | 1,55 |
| Interest Coverage | 2,79 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -1,94 | P/B Ratio | 1,10 |
| P/S Ratio | 0,65 | PEG Ratio | 0,00 |
| EV/EBITDA | 12,01 | Dividend Yield | 0,00% |
| Market Cap | 2,14B | Enterprise Value | 4,66B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,31B | 3,15B | 2,93B | 2,61B | 2,31B |
| Net Income | -1,10B | 255,61M | -21,67M | 273,14M | 190,64M |
| EPS (Diluted) | -12,16 | 2,78 | -0,24 | 2,98 | 2,10 |
| Gross Profit | 583,44M | 711,98M | 682,61M | 2,51B | 2,22B |
| Operating Income | 387,97M | 522,28M | 506,60M | 467,70M | 414,47M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,53B | 5,96B | 5,36B | 4,99B | 4,77B |
| Total Liabilities | 3,39B | 2,77B | 2,47B | 2,09B | 2,19B |
| Shareholders' Equity | 1,95B | 3,07B | 2,78B | 2,81B | 2,52B |
| Total Debt | 2,65B | 2,09B | 1,51B | 1,53B | 1,64B |
| Cash & Equivalents | 133,24M | 76,31M | 100,07M | 97,65M | 133,81M |
| Current Assets | 814,14M | 577,49M | 596,00M | 506,13M | 495,03M |
| Current Liabilities | 525,19M | 577,92M | 885,78M | 388,33M | 404,86M |